Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

Having it all: Women in wealthy countries consider what makes them happy

Money doesn’t buy happiness, but it is an important factor - both directly, by providing material comforts, and indirectly, by supporting an active approach to managing health and fitnessDoes wealth...

- PMLiVE

Digital influencer marketing

How good stories can drive value for brands, products and companies

- PMLiVE

AZ, BMS and Boehringer among UK Prix Galien finalists

They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda

In Memory

In Memory is a pioneering new short film that exemplifies Bedrock Multimedia’s industry leading approach to healthcare edutainment. It provides a captivating example of how film can be used to...

Bedrock Healthcare Communications

Millefeuille

This story of hope charts Élodie’s physical and mental struggles with psoriasis and psoriatic arthritis. With a little encouragement from her friend Holly, she regains the confidence to live a...

Bedrock Healthcare Communications

- PMLiVE

Just:: Health Communications becomes HAVAS Just::

Healthcare agency changes name one year after its acquisition by HAVAS Health

ABPI London offices

UK pharma HCP payment database goes live

Two-thirds of payments related to research and development work

- PMLiVE

NICE finally set to back wider use of Ferring’s Firmagon

And acknowledges drug's benefits for prostate cancer that spreads to the spine

- PMLiVE

Tracking comms trends: 2 + 2 = 7: bad maths, or good sense?

From multi-disciplinary teamwork to pharma’s reputation, value and access to global briefs, our contributors tackle some of the key topics in communications today

- PMLiVE

Life Healthcare Comms expands creative team

Chris Owens, Catriona Hampton and Kerry Stevenson join

Biogen promotes Dr Paul McKenzie

He becomes pharmaceutical operations and technology EVP

Bristol-Myers Squibb (BMS) building

BMS to explore new options for its immuno-oncology drug Opdivo

Partners with PsiOxis to research its use with enadenotucirev

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links